EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cells

Chunyu Jin, Linjie Zhao, Wubin Ma, Guofeng Zhao, Yujia Liu, Hanwen Zhang, Shenghong Ma, Likun Yao, Yuan Liu, Qiulian Wu, Huairui Yuan, Kailin Yang und 4 weitere

Cell Reports · 2026

DOI: 10.1016/j.celrep.2026.117498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Chunyu Jin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department and School of Medicine, San Diego, La Jolla, CA, USA. Electronic address: c3jin@ucsd.edu. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Enhancer Elements, Genetic, Mediator Complex, Chromosomes, Human, Pair 8. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycEnhancer Elements, GeneticMediator ComplexChromosomes, Human, Pair 8Gene AmplificationHumansCell Line, TumorProtein BindingGene Expression Regulation, NeoplasticAnimalsBinding SitesPromoter Regions, GeneticPancreatic Neoplasms

Stichwörter der Autor:innen

CP: cancerCP: molecular biologyCUT&TagMED30MYCenhancer activationgene amplificationglioblastomalow-affinity binding sitesmediator complexpancreatic cancertranscriptional program

Substanzen

Proto-Oncogene Proteins c-mycMediator Complex

Autor:innen und Institutionen

  • Department and School of Medicine, San Diego, La Jolla, CA, USA. Electronic address: c3jin@ucsd.edu.
  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Department and School of Medicine, San Diego, La Jolla, CA, USA.
  • Department of Pharmacology and Moores Cancer Center, San Diego, La Jolla, CA, USA.
  • Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
  • Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.

Förderung

  • NIA NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • NINDS NIH HHS
  • University of Texas Health Science Center at San Antonio
  • National Institutes of Health

Zitieren

APA

Jin, C., Zhao, L., Ma, W., Zhao, G., Liu, Y., Zhang, H., Ma, S., Yao, L., Liu, Y., Wu, Q., Yuan, H., Yang, K., Yuan, W., Ohgi, K., Rich, J. N., & Rosenfeld, M. G. (2026). Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cells. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117498

Vancouver

Jin C, Zhao L, Ma W, Zhao G, Liu Y, Zhang H, et al. Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cells. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117498

BibTeX
@article{Jin2026,
  author = {Jin, Chunyu and Zhao, Linjie and Ma, Wubin and Zhao, Guofeng and Liu, Yujia and Zhang, Hanwen and Ma, Shenghong and Yao, Likun and Liu, Yuan and Wu, Qiulian and Yuan, Huairui and Yang, Kailin and Yuan, Wei and Ohgi, Kenneth and Rich, Jeremy N and Rosenfeld, Michael G},
  title = {Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cells},
  journal = {Cell Reports},
  year = {2026},
  doi = {10.1016/j.celrep.2026.117498}
}
Kostenlos starten →